Asset

Total 50, page 1/3

No. Organization Therapeutic Area Product Type Title
50 Stanford SPARK Program Neurology Small molecule Parkinson's disease and Frontal Temporal Dementia
49 Ramot At Tel Aviv University Neurology Small molecule Novel Specific Disease-modifying PERK Activator for Huntington's Disease
48 Duke-NUS Medical School Neurology Small molecule Treatment of Seizures Associated with Angelman Syndrome
47 The Scripps Research lnstitute Neurology Small molecule Picrotoxinin-derived NCEs as Allosteric GABAAR antagonists
46 University Of Toronto Neurology Peptide Peptide Therapeutics for Parkinson’s Disease
45 Dana-Farber Neurology, Oncology Small molecule Selective Disruption of Histone Deacetylase Complexes by Protein Interaction Inhibitors to Treat Cancer and Neurological Disorders
44 Weill Cornell Medicine Oncology Small molecule Malic Enzyme 1 (ME1) Inhibitors for Pancreatic and Gastrointestinal Cancers
43 Weill Cornell Medicine Oncology Small molecule Inhibitors of MALT1 for the Treatment of Lymphomas
42 Weill Cornell Medicine Oncology Small molecule 6-Ethylthioinosine for the Treatment of Cancers that Overexpress Adenosine Kinase (ADK)
41 Cambridge Enterprise Ltd Oncology Small molecule Antibody Drug Conjugate Chemistry
40 Ramot At Tel Aviv University Oncology Small molecule Broad-Spectrum Metastasis Suppressing Compounds in Human Solid Tumors
39 Dana-Farber Oncology Small molecule KDM5 Selective Inhibitors for the Treatment of Multiple Myeloma and Other KDM-dependent Diseases
38 Dana-Farber Oncology Small molecule Highly Selective Focal Adhesion Kinase (FAK) Inhibitors
37 Dana-Farber Oncology Small molecule Targeting TIRR for Cancer Therapy: A Novel Target for p53 Reactivation
36 Dana-Farber Oncology Small molecule Small molecules that Block Proteasome-Associated Ubiquitin Receptor RPN13 Function
35 University Of Toronto Oncology Small molecule NUAK Inhibitors as Therapeutics for Cancer and Fibrosis
34 Cancer Research Horizons Oncology Small molecule CDC7 Inhibitors
33 NIH Oncology Small molecule Small Molecule Ephrin (Eph) Tyrosine Kinase Inhibitors for the Treatment of Colorectal Cancer and Other Eph Growth-dependent Solid Tumors
32 Boston University Oncology Small molecule TFCP2 Transcription Factor Inhibitors
31 Weill Cornell Medicine Oncology Antibody Conjugated Anti-CDCP1 Antibody-Drug Conjugate for the Treatment of Solid Tumors

TOP